Psychosis is a relatively common condition affecting about 3 in 1,000 Australians at any time. Psychosis generally occurs as part of other mental health conditions such as bipolar disorder or schizophrenia. Psychosis may also occur in association with other medical conditions such as Parkinson’s disease, Alzheimer’s, or postnatal depression. People may have a single episode of psychosis, several episodes with complete recovery, or recurring episodes throughout their lives. Psychosis is a serious and complex mental health condition. In an acute episode, a person with psychosis may be unable to differentiate what is actually happening from what they imagine is happening to them. They may be a danger to themselves or others if they act on their false beliefs. They may, for example, think that people are talking about them and accost those people and start arguing with them. The good news is that psychosis is treatable. The best outcomes are achieved when symptoms of psychosis are recognised early and treated by a psychiatrist with medications to alleviate the symptoms. This is only the first step in treatment. The guide focuses on providing a practical resource for people with psychosis to take an active role in their recovery and partner with a team of people in the community to build a healthy pattern of life with physical and psychological wellness, a strong support group, a network of friends, and a rewarding array of personal, community, and work-related activities to lead a full and productive life. The guide comes out of lived experience of a complex mental illness, negotiating through psychotic episodes, letting go of the old, understanding and acceptance of a different set of circumstances, building a life again, renegotiating relationships, starting again with work, and a career. Every journey is different. We hope the guide helps you on your journey.

This new edition describes a stage-specific model highlighting the risk, the clinical and biological factors present during the development of psychotic illness, and the best treatments available for each of these stages. Guides practitioners and researchers in the adoption of carefully planned management strategies fully integrating treatment with prevention.

The Maudsley® Prescribing Guidelines in Psychiatry The new edition of the world-renowned reference guide on the use of medications for patients presenting with mental health problems The Maudsley Prescribing Guidelines in Psychiatry is the essential evidence-based handbook on the safe and effective prescribing of psychotropic agents. Covering both common and complex prescribing situations encountered in day-to-day clinical practice, this comprehensive resource provides expert guidance on drug choice, minimum and maximum doses, adverse effects, switching medications, prescribing for special patient groups, and more. Each clear and concise chapter includes an up-to-date reference list providing easy access to the evidence on which the guidance is based. The fourteenth edition has been fully updated to incorporate the latest available research, the most recent psychotropic drug introductions, and all psychotropic drugs currently used in the UK, USA, Canada, Australia, New Zealand, and Japan. Several new sections cover topics such as deprescribing of major psychiatric drugs, prescribing psychotropics at the end of life, the treatment of agitated delirium, the genetics of clozapine prescribing, the use of weekly penfluridol, and the treatment of psychotropic withdrawal. Featuring contributions by an experienced team of psychiatrists and specialist pharmacists, the new edition of The Maudsley Prescribing Guidelines in Psychiatry: Provides succinct coverage of drug treatment of psychiatric conditions and formulating prescribing policy in mental health Covers a wide range of psychiatric conditions including schizophrenia, bipolar disorder, depression and anxiety, borderline personality, eating disorders, and many others Provides advice on prescribing for children and adolescents, older people, pregnant women, and other special patient groups Offers new sections on genetic prescribing, long-acting injectable formulations, ketamine administration and uses, and dopamine super-sensitivity Includes referenced information on off-label prescribing, potential interactions with other substances such as alcohol, tobacco, and caffeine, and treating patients with comorbid physical conditions Whether in the doctor’s office, in the clinic, or on the ward, The Maudsley Prescribing Guidelines in Psychiatry, Fourteenth Edition is a must-have for psychiatrists, pharmacists, neuropharmacologists, clinical psychologists, nurses, and other healthcare professionals working in mental health, as well as trainees and students in medicine, pharmacy, and nursing.

Psychiatric comorbidities such as depression, anxiety and substance use are extremely common amongst people with schizophrenia. They add to poor clinical outcomes and disability, yet are often not at the forefront of the minds of clinicians, who tend to concentrate on assessing and treating the core symptoms of schizophrenia, notably delusions and hallucinations. There is an imperative to assess every patient with schizophrenia for psychiatric comorbidities, as they might masquerade as core psychotic symptoms and also because they warrant treatment in their own right. This volume addresses these issues using a clinical lens informed by the current literature. Published as part of the Oxford Psychiatry Library series, the book serves as a concise and practical reference for busy clinicians.

These guidelines from NICE set out clear recommendations, based on the best available evidence, for health care professionals on how to work with and implement physical, psychological and service-level interventions for people with various mental health conditions.The book contains the full guidelines that cannot be obtained in print anywhere else. It brings together all of the evidence that led to the recommendations made, detailed explanations of the methodology behind their preparation, plus an overview of the condition covering detection, diagnosis and assessment, and the full range of treatment and care approaches. There is a worse prognosis for psychosis and schizophrenia when onset is in childhood or adolescence, and this new NICE guideline puts much-needed emphasis on early recognition and assessment of possible psychotic symptoms. For the one-third of children and young people who go on to experience severe impairment as a result of psychosis or schizophrenia the guideline also offers comprehensive advice from assessment and treatment of the first episode through to promoting recovery.This guideline reviews the evidence for recognition and management of psychosis and schizophrenia in children and young people across the care pathway, encompassing access to and delivery of services, experience of care, recognition and management of at-risk mental states, psychological and pharmacological interventions, and improving cognition and enhancing engagement with education and employment.

This book presents a series of cases of psychosocial interventions with schizophrenia and other serious mental health difficulties. Co-authored by a range of professionals in different roles, as well as carers and service users. Captures the benefits of a true alliance between the service user and their clinical worker. Details the skills and knowledge needed for interventions in a range of settings, including outreach work and family work, treatment on acute wards, as well as organisational change. Introductions and conclusions to each case examine the implications for practice and policy.

Outlines a comprehensive, evidence-based approach to coordinating psychopharmacological and psychotherapeutic treatments Cognitive Behavioral Psychopharmacology takes an evidence-based approach to demonstrating the advantages of biopsychosocial integration in interventions for the major psychiatric diagnoses. It is the first and only book to translate the current evidence for cognitive behavioral, psychosocial, and pharmacologic approaches to mental health disorders into clear guidance for clinical practice. There is a burgeoning movement in mental health to acknowledge the entire person’s functioning across physical, psychological and social spheres, and to integrate medical as well as psychological and social interventions to address the entire spectrum of presenting problems. This book bridges a gap in the professional mental health literature on the subject of standalone versus combined treatment approaches. It reviews the current state of integrative care, and makes a strong case that optimal outcomes are best achieved by an awareness of how and why the cognitive-behavioral aspects of prescribed medical and psychological interventions influence treatment. Each disorder-specific chapter is authored by a prescriber and psychotherapist team who consider all the evidence around treatments and combinations, providing outcome conclusions and concise tables of recommended front-line interventions. Provides a biopsychsocial perspective that integrates the medical, psychotherapeutic, family, and community aspects of the therapeutic process Brings together and compares the current evidence for and against treatments that combine psychopharmacology and cognitive behavioral psychotherapy for major psychiatric diagnoses Outlines an evidence-based approach to determining which combination of treatments is most appropriate for each of the major psychiatric diagnoses Describes, in a way that is accessible to both prescribers and therapists, when and how cognitive behavioral therapy can be integrated into pharmacotherapy The book will appeal to a wide range of mental health professionals, including psychologists, psychiatrists, clinical social workers, licensed professional counselors, marriage and family therapists, and addictions counselors. It also will be of interest to primary care physicians and nurse practitioners who work side by side with mental health professionals.

An invaluable guide to psychiatric presentation, diagnosis and treatment in a primary care setting.

Schizophrenia is a devastating disorder that starts in early life and can lead to lifelong disability. It is a major public health challenge for all cultures and all countries. Clinical practice must therefore focus on early intervention, optimal treatment, shared decision-making and long-term recovery. "By listening to patients' experiences, alongside the latest research, we now know much more about 'what works'," say the authors of this fully updated fourth edition of 'Fast Facts: Schizophrenia'. In this highly readable resource, they cover the present state of knowledge about the neurobiology, diagnosis and treatment of schizophrenia, including: • emerging evidence from genome-wide association studies for multiple susceptibility genes • DSM-5 diagnostic criteria plus discussion of alternative classification systems • a comprehensive review of drug and non-drug treatment strategies and how to improve adherence • a new management principles chapter that emphasizes the importance of coordinated multidisciplinary care • the latest findings of structural and functional imaging studies. With good care delivered by knowledgeable compassionate health professionals, many people will recover at least partially from their first episode of psychosis and live a fulfilling life. Written from an international perspective, 'Fast Facts: Schizophrenia' will refresh and update family physicians, psychiatrists in training, mental health nurses and medical students - in fact, all health professionals - who need to know about the disorder and need to know it quickly. Contents: • A brief history • Symptoms and diagnosis • Epidemiology: risk factors and outcome • Genetics • Developmental theories and environmental factors • Neuroanatomy and structural imaging • Neuropsychology and functional imaging • Neurochemistry • Management principles • Pharmacological treatment • Psychosocial interventions and non-drug treatment • Early intervention and prevention • Useful resources

Authored by over 500 internationally acclaimed expert editors and chapter authors from around the world. Completely updated and expanded with almost 40 new chapters. Significantly increased attention to the role of culture in all aspects of evaluation and care. New sections on Digital Mental Health Services and Technologies, Treatment Issues in Specific Populations and Settings, and on Prevention, Systems of Care, and Psychosocial Aspects of Treatment address key advances. This edition is the first comprehensive reference work to cover the entire field of psychiatry in an updateable format, ensuring access to state of the art information. Earlier editions were called “the best current textbook of psychiatry” by the New England Journal of Medicine, and “the gold standard” by the American Journal of Psychiatry. Tasman’s Psychiatry, 5th Edition, builds on the initial vision in prior editions of approaching psychiatric evaluation and care from an integrative bio-psycho-social-cultural perspective. It is designed to be an essential and accessible reference for readers at any level of experience. This editorial approach encompasses the importance of the first encounter between patient and clinician, followed by the complex task of beginning to develop a therapeutic relationship and to develop and implement a treatment plan in collaboration with the patient. The importance of increasing attention to the role of culture and social determinants of mental health is reflected both in specific chapters and in components of many chapters throughout the book, especially in those pertaining to clinical evaluation, the therapeutic alliance, and treatment. The global scope of this edition is reflected throughout the book, including the section on psychiatric disorders where evaluation using both ICD 11 and DSM 5-TR is discussed. Most chapters are authored by experts from at least two different countries or continents, adding a critically important dimension which often is missing in major psychiatric textbooks. Tasman’s Psychiatry, 5th Edition, is an essential reference for all medical professionals and students who need a trusted reference or learning tool for psychiatry, psychology, clinical research, social work, counseling, therapy, and all others.